Morgan Stanley
ALXA

Morgan Stanley’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Morgan Stanley’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-782,689
Closed -$379K – 6867
2016
Q1 		$379K Sell
782,689
-186,145
-19% -$81.4K ﹤0.01% 4602
2015
Q4 		$678K Sell
968,834
-84
-0% -$87 ﹤0.01% 4331
2015
Q3 		$1.19M Sell
968,918
-853
-0.1% -$997 ﹤0.01% 3970
2015
Q2 		$1.06M Sell
969,771
-2,372
-0.2% -$3.56K ﹤0.01% 4158
2015
Q1 		$2.01M Sell
972,143
-8,212
-0.8% -$16.9K ﹤0.01% 3587
2014
Q4 		$1.46M Sell
980,355
-53,631
-5% -$95.7K ﹤0.01% 3828
2014
Q3 		$2.41M Buy
1,033,986
+5,739
+0.6% +$21.9K ﹤0.01% 3276
2014
Q2 		$4.7M Buy
1,028,247
+91,017
+10% +$393K ﹤0.01% 2720
2014
Q1 		$4.15M Buy
937,230
+221,830
+31% +$1.14M ﹤0.01% 2748
2013
Q4 		$3.38M Buy
715,400
+25,386
+4% +$125K ﹤0.01% 2942
2013
Q3 		$3.53M Buy
690,014
+404,899
+142% +$1.91M ﹤0.01% 2758
2013
Q2 		$1.24M Buy
+285,115
New +$1.29M ﹤0.01% 3541

Morgan Stanley's ALXA Position: Q2 2016 in Review

Morgan Stanley sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 782,689 shares — an estimated $379K sold.

Morgan Stanley first reported a position in ALXA in Q2 2013 and held it in 12 quarters. The position peaked at $4.7M in Q2 2014. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Morgan Stanley reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Morgan Stanley sold 782,689 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $379K.
  • Morgan Stanley first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Morgan Stanley's Alexza Pharmaceuticals Inc position peaked at $4.7M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.